General Resources / Legal Resources / Medical Resources / Briefing Papers / State Activity    
Hospital Closures / Preventable Tragedies / Press Room / Search Our Site / Home


MEDIA ADVISORY

Treatment Advocacy Center

and

Public Citizen


FOR IMMEDIATE RELEASE
November 13, 2003

CONTACT:

Shannon Little, PC, (202) 588-7742
Alicia Aebersold, TAC, (703) 294-6008
Angela Bradbery, PC (202) 588-7741

Federal agency responsible for mental health research gives short shrift to serious mental illnesses

New report shows failure to fund essential research

   

WHAT:     

Press conference to release report showing the continuing failure of the National Institute of Mental Health (NIMH) to sufficiently fund meaningful research of serious mental illnesses.

The Treatment Advocacy Center and Public Citizen have found that the NIMH allocates only a small portion of its research grants to scientific research into serious mental illnesses – bipolar disorder, schizophrenia, autism, panic disorder, obsessive-compulsive disorder and severe forms of depression – in spite of the millions of Americans who suffer from these illnesses and their enormous economic and social costs. From 1997-2002, the NIMH rejected funding for many promising research proposals on serious mental illnesses and instead funded much research on topics that had no relationship at all to these brain diseases, such as pre-schoolers’ conception of love and characteristics of sleep in insects. Although the NIMH budget doubled during those years, the proportion of money spent on researching mental illness declined significantly.

WHEN:    

11 a.m., Wednesday, Nov. 19

  WHO:

E. Fuller Torrey, M.D., lead author, president of the board, Treatment Advocacy Center
Mary Zdanowicz, executive director, Treatment Advocacy Center
Jon Stanley, assistant director, Treatment Advocacy Center, has bipolar disorder
Sidney Wolfe, M.D., director, Public Citizen's Health Research Group

 

 WHERE:  

Public Citizen
1600 20th St. N.W., Washington, D.C.
(The office is located at the northwest corner of Q and 20th Streets, N.W.)

         

###

The Treatment Advocacy Center (www.treatmentadvocacycenter.org) is a national nonprofit organization dedicated to eliminating barriers to the timely and effective treatment of severe mental illnesses. TAC promotes laws, policies, and practices for the delivery of psychiatric care and supports the development of innovative treatments for and research into the causes of severe and persistent psychiatric illnesses, such as schizophrenia and bipolar disorder.

Public Citizen is a national nonprofit consumer advocacy organization based in Washington, D.C. For more information, please visit www.citizen.org.

ADDITIONAL INFO
NIMH's failure to support sufficient research on severe mental illnesses | consequences of lack of treatment
about the Treatment Advocacy Center | full bio of Dr. Torrey with photo


general resources | legal resources | medical resources | briefing papers | state activity   
hospital closures | preventable tragedies | press room | search | home

FootnoteImage2.jpg (1088 bytes)
Treatment Advocacy Center

The contents of TAC's website are copyrighted by the Treatment Advocacy Center unless otherwise indicated. All rights reserved and content may be reproduced, downloaded, disseminated, or transferred, for single use, or by nonprofit organizations for educational purposes only, if correct attribution is made. TAC is an I.R.C. � 501(c)(3) tax-exempt corporation. Donations are appreciated and are eligible for the charitable contribution deduction under the provisions of I.R.C. � 170. Please note that TAC does not accept funding from pharmaceutical companies or entities involved in the sale, marketing, or distribution of such products.

Treatment Advocacy Center (TAC), 200 N. Glebe Road, Suite 730, Arlington, VA 22203
703 294 6001/6002 (phone) | 703 294 6010 (fax) | www.treatmentadvocacycenter.org (website)
[email protected] (general email) | [email protected] (press contact)
[email protected] (webmaster)